CIRRUS LOGIC INC, 10-Q filed on 2/1/2017
Quarterly Report
Document and Entity Information
9 Months Ended
Dec. 24, 2016
Jan. 27, 2017
Document and Entity Information [Abstract]
 
 
Document Type
10-Q 
 
Amendment Flag
false 
 
Entity Registrant Name
CIRRUS LOGIC INC 
 
Entity Central Index Key
0000772406 
 
Entity Filer Category
Large Accelerated Filer 
 
Entity Well-known Seasoned Issuer
Yes 
 
Entity Current Reporting Status
Yes 
 
Entity Voluntary Filers
No 
 
Document Period End Date
Dec. 24, 2016 
 
Document Fiscal Year Focus
2017 
 
Document Fiscal Period Focus
Q3 
 
Current Fiscal Year End Date
--03-25 
 
Entity Common Stock, Shares Outstanding
 
64,231,952 
Consolidated Condensed Balance Sheets (USD $)
In Thousands, unless otherwise specified
Dec. 24, 2016
Mar. 26, 2016
Assets
 
 
Cash and cash equivalents
$ 310,375 
$ 168,793 
Marketable securities
72,342 
60,582 
Accounts receivable, net
246,630 
88,532 
Inventories
154,128 
142,015 
Prepaid assets
24,223 
29,924 
Other current assets
17,524 
16,283 
Total current assets
825,222 
506,129 
Long-term marketable securities
20,631 
Property and equipment, net
167,933 
162,656 
Intangibles, net
144,005 
162,832 
Goodwill
287,518 
287,518 
Deferred tax assets
34,737 
25,772 
Other assets
13,990 
16,345 
Total assets
1,473,405 
1,181,883 
Liabilities and Stockholders' Equity
 
 
Accounts payable
154,930 
71,619 
Accrued salaries and benefits
33,122 
21,239 
Software license agreement
12,310 
20,308 
Other accrued liabilities
12,377 
14,958 
Total current liabilities
212,739 
128,124 
Debt
100,000 
160,439 
Software license agreement long-term
3,131 
8,136 
Other long-term liabilities
53,500 
25,701 
Total long-term liabilities
156,631 
194,276 
Stockholders' Equity:
 
 
Capital stock
1,247,191 
1,203,496 
Accumulated deficit
(141,027)
(344,345)
Accumulated other comprehensive income
(2,129)
332 
Total stockholders' equity
1,104,035 
859,483 
Total liabilities and stockholders' equity
$ 1,473,405 
$ 1,181,883 
Consolidated Condensed Statements of Income (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Dec. 24, 2016
Dec. 26, 2015
Dec. 24, 2016
Dec. 26, 2015
Consolidated Condensed Statements of Income [Abstract]
 
 
 
 
Net sales
$ 523,029 
$ 347,863 
$ 1,211,076 
$ 937,252 
Cost of sales
267,877 
182,952 
617,540 
497,666 
Gross profit
255,152 
164,911 
593,536 
439,586 
Operating expenses:
 
 
 
 
Research and development
76,079 
70,290 
225,686 
203,383 
Selling, general and administrative
32,884 
30,632 
95,513 
89,854 
Patent agreement and other
 
78 
 
(11,670)
Total operating expenses
108,963 
101,000 
321,199 
281,567 
Income from operations
146,189 
63,911 
272,337 
158,019 
Interest income
415 
165 
978 
634 
Interest expense
(765)
(863)
(3,020)
(2,786)
Other expense
(47)
(818)
(161)
(991)
Income before income taxes
145,792 
62,395 
270,134 
154,876 
Provision for income taxes
23,751 
21,011 
43,983 
45,258 
Net income
$ 122,041 
$ 41,384 
$ 226,151 
$ 109,618 
Basic earnings per share
$ 1.91 
$ 0.65 
$ 3.59 
$ 1.73 
Diluted earnings per share
$ 1.83 
$ 0.63 
$ 3.41 
$ 1.66 
Basic weighted average common shares outstanding
63,837 
63,328 
63,025 
63,316 
Diluted weighted average common shares outstanding
66,748 
65,761 
66,378 
66,184 
Consolidated Condensed Statements of Comprehensive Income (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Dec. 24, 2016
Dec. 26, 2015
Dec. 24, 2016
Dec. 26, 2015
Consolidated Condensed Statements of Comprehensive Income [Abstract]
 
 
 
 
Net income
$ 122,041 
$ 41,384 
$ 226,151 
$ 109,618 
Other comprehensive income (loss), before tax
 
 
 
 
Foreign currency translation
(500)
(4)
(247)
174 
Unrealized gain (loss) on marketable securities
40 
(104)
31 
(183)
Actuarial loss on pension plan
(2,646)
 
(2,646)
 
Reclassification of actuarial (gain) loss to net income
(27)
17 
(80)
49 
Benefit for income taxes
461 
37 
481 
51 
Comprehensive income
$ 119,369 
$ 41,330 
$ 223,690 
$ 109,709 
Consolidated Condensed Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Dec. 24, 2016
Dec. 26, 2015
Cash flows from operating activities:
 
 
Net income
$ 226,151 
$ 109,618 
Adjustments to reconcile net income to net cash provided by operating activities:
 
 
Depreciation and amortization
47,989 
43,254 
Stock compensation expense
28,708 
24,717 
Deferred income taxes
5,285 
8,021 
Loss on retirement or write-off of long-lived assets
424 
1,405 
Actuarial (gain) loss amortization on defined benefit pension plan
64 
 
Excess tax benefit from employee stock awards
 
(9,350)
Other non-cash charges
(2,547)
14,381 
Net change in operating assets and liabilities:
 
 
Accounts receivable, net
(158,098)
(15,066)
Inventories
(12,113)
(53,527)
Other current assets
(1,279)
(4,645)
Accounts payable and other accrued liabilities
96,673 
861 
Deferred income
 
(1,943)
Income taxes payable
13,636 
(1,428)
Net cash provided by operating activities
244,893 
116,298 
Cash flows from investing activities:
 
 
Maturities and sales of available-for-sale marketable securities
157,234 
117,397 
Purchases of available-for-sale marketable securities
(148,342)
(22,672)
Purchases of property, equipment and software
(26,380)
(33,720)
Investments in technology
(8,920)
(3,981)
Acquisition of businesses, net of cash obtained
 
(36,788)
Increase in deposits and other assets
 
(2,012)
Net cash (used in) provided by investing activities
(26,408)
18,224 
Cash flows from financing activities:
 
 
Principal payments on long-term revolver
(60,439)
(20,000)
Debt issuance costs
(2,152)
 
Payments on capital lease agreements
(699)
 
Issuance of common stock, net of shares withheld for taxes
14,869 
4,958 
Repurchase of stock to satisfy employee tax withholding obligations
(13,043)
(6,459)
Repurchase and retirement of common stock
(15,439)
(39,200)
Excess tax benefit from employee stock awards
 
9,350 
Net cash used in financing activities
(76,903)
(51,351)
Net decrease in cash and cash equivalents
141,582 
83,171 
Cash and cash equivalents at beginning of period
168,793 
168,793 
Cash and cash equivalents at end of period
$ 310,375 
$ 159,572 
Basis of Presentation
Basis of Presentation

1.     Basis of Presentation



The consolidated condensed financial statements have been prepared by Cirrus Logic, Inc. (“Cirrus Logic,” “we,” “us,” “our,” or the “Company”) pursuant to the rules and regulations of the Securities and Exchange Commission (the “Commission”).  The accompanying unaudited consolidated condensed financial statements do not include complete footnotes and financial presentations.  As a result, these financial statements should be read along with the audited consolidated financial statements and notes thereto for the year ended March 26, 2016, included in our Annual Report as amended on Form 10-K/A on February 1, 2017.  In our opinion, the financial statements reflect all material adjustments, including normal recurring adjustments, necessary for a fair presentation of the financial position, operating results and cash flows for those periods presented.  The preparation of financial statements in conformity with United States (“U.S.”) generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect reported assets, liabilities, revenues and expenses, as well as disclosure of contingent assets and liabilities.  Actual results could differ from those estimates and assumptions.  Moreover, the results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the entire year.  Additionally, prior period amounts have been adjusted to conform to current year presentation.   

Recently Issued Accounting Pronouncements
Recently Issued Accounting Pronouncements

2.     Recently Issued Accounting Pronouncements



In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (ASC Topic 606).  The purpose of this ASU is to converge revenue recognition requirements per U.S. GAAP and International Financial Reporting Standards (IFRS).  The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.  In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date after public comment supported a proposal to delay the effective date of this ASU to annual reporting periods beginning after December 15, 2017, including interim reporting periods within that reporting period.  The Company is currently evaluating the impact of this ASU on its financial statements and expects no material modifications.  



In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.  The amendments in this ASU provide guidance about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures.  The amendments are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter.  Early application is permitted.  The Company expects no material modifications to its financial statements.



In April 2015, the FASB issued ASU No. 2015-03, Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs.  The amendments in this update require that debt issuance costs related to a recognized debt liability are presented in the balance sheet as a direct deduction from the carrying amount of that debt liability and that the amortization of debt issuance costs is reported as interest expense.  ASU 2015-03 is to be applied retrospectively and represents a change in accounting principle.  In August 2015, the FASB issued FASB ASU No. 2015-15, Interest—Imputation of Interest (Subtopic 835-30): Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements.  ASU 2015-15 clarified the presentation and subsequent measurement of debt issuance costs related to line-of-credit arrangements.  Debt issuance costs related to a line-of-credit arrangement may be presented in the balance sheet as an asset and subsequently amortized ratably over the term of the arrangement regardless of whether there are any outstanding borrowings.  Both ASU 2015-03 and ASU 2015-15 are effective for fiscal years beginning after December 15, 2015, including interim periods within those fiscal years.  Earlier adoption is permitted for financial statements that have not been previously issued.  The Company adopted these ASUs in the current fiscal year with no material impact.    



In April 2015, the FASB issued ASU No. 2015-04, Compensation – Retirement Benefits (Topic 715): Practical Expedient for the Measurement Date of an Employer’s Defined Benefit Obligation and Plan Assets.  The ASU is part of the FASB’s “Simplification Initiative” to reduce complexity in accounting standards.  The FASB decided to permit entities to measure defined benefit plan assets and obligations as of the month-end that is closest to their fiscal year-end.  An entity is required to disclose the accounting policy election and the date used to measure defined benefit plan assets and obligations in accordance with the amendments in this update.  The amendments in this update are effective for public business entities for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years, with earlier application permitted.  The Company adopted this ASU in the first quarter of the current fiscal year, with no modifications to its financial statements.  The Company’s plan assets and obligations are measured as of the fiscal year-end. 



In July 2015, the FASB issued ASU No. 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory.  This ASU requires companies to subsequently measure inventory at the lower of cost and net realizable value versus the previous lower of cost or market.  The amendments in this update are effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years, to be applied prospectively.  Early application is permitted. The Company expects no material modifications to its financial statements as a result.



In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). The FASB issued this update to increase transparency and comparability by recognizing lease assets and lease liabilities on the balance sheet and disclosing key leasing arrangement details.  Lessees would recognize operating leases on the balance sheet under this ASU — with the future lease payments recognized as a liability, measured at present value, and the right-of-use asset recognized for the lease term. A single lease cost would be recognized over the lease term.  For terms less than twelve months, a lessee would be permitted to make an accounting policy election to recognize lease expense for such leases generally on a straight-line basis over the lease term.  This ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years.  Early adoption is permitted.  The Company is currently evaluating the impact of this ASU.



In March 2016, the FASB issued ASU 2016-09, Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting.  This ASU requires all excess tax benefits and deficiencies to be recognized as income tax benefit / expense in the income statement and presented as an operating activity in the statement of cash flows.  Forfeitures can be calculated based on either the estimated number of awards that are expected to vest, as required by current guidance, or when forfeitures actually occur.  This ASU is effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods.  Early adoption is permitted, but all amendments must be adopted in the same period and any adjustments should be reflected as of the beginning of the fiscal year if adopted in an interim period.  The Company early adopted in the current fiscal quarter, which resulted in the following:



·

We recorded excess tax benefits within income tax expense, rather than in additional paid-in capital (“APIC”), of $2.2 million, $8.0 million and $10.8 million for the first, second and third quarters of fiscal year 2017, respectively. 

·

We recorded a cumulative-effect adjustment as of March 27, 2016 to increase retained earnings by $5.6 million, with a corresponding increase to deferred tax assets, to recognize net operating loss and tax credit carryforwards attributable to excess tax benefits on stock-based compensation that had not been previously recognized.

·

We now include the excess tax benefits in net operating cash rather than net financing cash in our Consolidated Condensed Statements of Cash Flows.  



We applied this change in presentation prospectively and thus prior years have not been adjusted.



We elected not to change our policy on accounting for forfeitures and continue to estimate forfeitures expected to occur to determine the amount of compensation cost to be recognized in each period.



The adoption of this new guidance impacted our previously reported quarterly results for fiscal year 2017 as follows:







 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 



 

Three Months Ended

 

 

Six Months Ended



 

June 25, 2016

 

September 24, 2016

 

 

September 24, 2016



 

As reported

 

As adjusted

 

As reported

 

As adjusted

 

 

As reported

 

As adjusted



 

(in thousands, except per share data)

Consolidated Condensed Statements of Income:

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax expense

$

5,805 

$

3,598 

$

24,608 

$

16,634 

 

$

30,413 

$

20,232 

Net income

$

15,864 

$

18,071 

$

78,065 

$

86,039 

 

$

93,929 

$

104,110 

Basic net income per share

$

0.25 

$

0.29 

$

1.24 

$

1.37 

 

$

1.50 

$

1.66 

Diluted net income per share

$

0.24 

$

0.27 

$

1.19 

$

1.30 

 

$

1.43 

$

1.58 

Weighted average shares used in diluted net income per share computation

 

65,232 

 

65,723 

 

65,717 

 

66,410 

 

 

65,521 

 

66,101 



 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated Condensed Statements of Cash Flows:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net cash provided by operating activities

$

12,226 

$

12,756 

$

19,990 

$

24,091 

 

$

32,216 

$

36,847 

Net cash used in financing activities

$

(13,140)

$

(13,670)

$

(13,859)

$

(17,960)

 

$

(26,999)

$

(31,630)





In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.  This ASU requires credit losses on available-for-sale debt securities to be presented as an allowance rather than a write-down. Unlike current U.S. GAAP, the credit losses could be reversed with changes in estimates, and recognized in current year earnings. This ASU is effective for annual periods beginning after December 15, 2019, and interim periods within those annual periods.  Early adoption is permitted for annual periods beginning after December 15, 2018, including interim periods.  The Company is currently evaluating the impact of this ASU with no expected material impact. 



In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments.  This ASU covers several cash flow issues, including the presentation of contingent consideration payments made after a business combination.  Cash payments up to the amount of the liability recognized at the acquisition date (including measurement-period adjustments) should be classified as financing activities.  This ASU is effective for annual periods beginning after December 15, 2017, and interim periods within those annual periods.  Early adoption is permitted, including in an interim period, with a required retrospective transition method applied to each period presented.  The Company is currently evaluating the impact of this ASU. 



In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory.  This ASU relates to non-inventory intercompany asset transfers.  This ASU is effective for annual periods beginning after December 15, 2017, and interim periods within those annual periods.  Early adoption is permitted, as of the beginning of an annual reporting period.  The guidance requires companies to apply a modified retrospective approach with a cumulative catch-up adjustment to beginning retained earnings in the period of adoption.  The Company is currently evaluating the impact of this ASU.

Marketable Securities
Marketable Securities

3.     Marketable Securities



The Company’s investments that have original maturities greater than 90 days have been classified as available-for-sale securities in accordance with U.S. GAAP.  Marketable securities are categorized on the consolidated condensed balance sheet as short- and long-term marketable securities, as appropriate.



The following table is a summary of available-for-sale securities at December 24, 2016 (in thousands):

 







 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

Estimated



 

 

 

Gross

 

Gross

 

Fair Value



Amortized

 

Unrealized

 

Unrealized

 

(Net Carrying

As of December 24, 2016

Cost

 

Gains

 

Losses

 

Amount)

Corporate debt securities

$

36,052 

 

$

-

 

$

(36)

 

$

36,016 

Commercial paper

 

36,354 

 

 

-

 

 

(28)

 

 

36,326 

Total securities

$

72,406 

 

$

-

 

$

(64)

 

$

72,342 



The Company’s specifically identified gross unrealized losses of $64 thousand related to 18 different securities with total amortized cost of approximately $72.4 million at December 24, 2016.   Four securities had been in a continuous unrealized loss position for more than 12 months as of December 24, 2016.  The gross unrealized loss on these securities was less than one percent of the position value.  Because the Company does not intend to sell the investments at a loss and it is not more likely than not that the Company will be required to sell the investments before recovery of its amortized cost basis, it did not consider the investment in these securities to be other-than-temporarily impaired at December 24, 2016.   



The following table is a summary of available-for-sale securities at March 26, 2016 (in thousands):







 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

Estimated



 

 

 

Gross

 

Gross

 

Fair Value



 

Amortized

 

Unrealized

 

Unrealized

 

(Net Carrying

As of March 26, 2016

 

Cost

 

Gains

 

Losses

 

Amount)

Corporate debt securities

$

 

81,310 

 

$

 

$

(100)

 

$

81,213 



The Company’s specifically identified gross unrealized losses of $100 thousand related to 21 different securities with total amortized cost of approximately $64.7 million at March 26, 2016Two securities had been in a continuous loss position for more than 12 months as of March 26, 2016, both of which have matured in the current fiscal year.  Because the Company did not intend to sell the investments at a loss and it was not more likely than not that the Company would be required to sell the investments before recovery of its amortized cost basis, it did not consider the investment in these securities to be other-than-temporarily impaired at March 26, 2016.  



The cost and estimated fair value of available-for-sale securities by contractual maturities were as follows (in thousands):





 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 



 

December 24, 2016

 

March 26, 2016



 

Amortized

 

Estimated

 

Amortized

 

Estimated



 

Cost

 

Fair Value

 

Cost

 

Fair Value

Within 1 year

 

$

72,406 

 

$

72,342 

 

$

60,603 

 

$

60,582 

After 1 year

 

 

 -

 

 

 -

 

 

20,707 

 

 

20,631 

Total

 

$

72,406 

 

$

72,342 

 

$

81,310 

 

$

81,213 



Fair Value of Financial Instruments
Fair Value of Financial Instruments

4.     Fair Value of Financial Instruments



The Company has determined that the only assets and liabilities in the Company’s financial statements that are required to be measured at fair value on a recurring basis are the Company’s cash equivalents, investment portfolio, pension plan assets / liabilities and contingent consideration.  The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement.    The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).





 

 



 

 

   

Level 1 - Quoted prices in active markets for identical assets or liabilities.

   

Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

   

Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.



 

 



The Company’s cash equivalents and investment portfolio assets consist of corporate debt securities, money market funds, and commercial paper and are reflected on our consolidated condensed balance sheets under the headings cash and cash equivalents, marketable securities, and long-term marketable securities.  The Company determines the fair value of its investment portfolio assets by obtaining non-binding market prices from its third-party portfolio managers on the last day of the quarter, whose sources may use quoted prices in active markets for identical assets (Level 1 inputs) or inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) in determining fair value.



In connection with one of the Company’s second quarter fiscal year 2016 acquisitions, the Company reported contingent consideration based upon achievement of certain milestones.  This liability is classified as Level 3 and valued using a discounted cash flow model.  The assumptions used in preparing the discounted cash flow include discount rate estimates and cash flow amounts.  See additional details below. 



The Company’s long-term revolving facility, described in Note 7, bears interest at a base rate plus applicable margin or LIBOR plus applicable margin.  As of December 24, 2016, the fair value of the Company’s long-term revolving facility approximates carrying value.



As of December 24, 2016 and March 26, 2016, the Company classified all of its investment portfolio and pension plan assets and liabilities as Level 1 or Level 2 assets and liabilities.  The only Level 3 liability is the contingent consideration described above and below.  The Company has no Level 3 assets.  There were no transfers between Level 1, Level 2, or Level 3 measurements for the nine months ending December 24, 2016. 



The following summarizes the fair value of our financial instruments at December  24, 2016, exclusive of pension plan assets and liabilities (in thousands):

The following summarizes the fair value of our financial instruments, exclusive of pension plan assets and liabilities, at December 24, 2016, (in thousands):

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 



Quoted Prices

 

 

 

 

 

 



in Active

 

Significant

 

 

 

 



Markets for

 

Other

 

Significant

 

 



Identical

 

Observable

 

Unobservable

 

 



Assets

 

Inputs

 

Inputs

 

 



Level 1

 

Level 2

 

Level 3

 

Total

Assets:

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

 

 

Money market funds

$

224,094 

 

$

 -

 

$

 -

 

$

224,094 



 

 

 

 

 

 

 

 

 

 

 

Available-for-sale securities

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

$

 -

 

$

36,016 

 

$

 -

 

$

36,016 

Commercial paper

 

 -

 

 

36,326 

 

 

 -

 

 

36,326 



$

 -

 

$

72,342 

 

$

 -

 

$

72,342 



 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

Other accrued liabilities

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration

$

 -

 

$

 -

 

$

1,239 

 

$

1,239 

Other long-term liabilities

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration

$

 -

 

$

 -

 

$

4,608 

 

$

4,608 





The following summarizes the fair value of our financial instruments at March 26, 2016, exclusive of pension plan assets and liabilities (in thousands):



 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 



Quoted Prices

 

 

 

 

 

 



in Active

 

Significant

 

 

 

 



Markets for

 

Other

 

Significant

 

 



Identical

 

Observable

 

Unobservable

 

 



Assets

 

Inputs

 

Inputs

 

 



Level 1

 

Level 2

 

Level 3

 

Total

Cash equivalents

 

 

 

 

 

 

 

 

 

 

 

Money market funds

$

79,256 

 

$

 -

 

$

 -

 

$

79,256 



 

 

 

 

 

 

 

 

 

 

 

Available-for-sale securities

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

$

 -

 

$

81,213 

 

$

 -

 

$

81,213 



 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

Other accrued liabilities

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration

$

 -

 

$

 -

 

$

4,709 

 

$

4,709 

Other long-term liabilities

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration

$

 -

 

$

 -

 

$

4,359 

 

$

4,359 



Contingent consideration

The following summarizes the fair value of the liability for contingent consideration at December 24, 2016:





 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 



 

 

Maximum Value if Milestones Achieved
(in thousands)

 

Estimated Discount Rate (%)

 

 

Fair Value
(in thousands)

Tranche A - 18 month earn out period

 

$

5,000 

 

7.0 

 

$

1,239 

Tranche B - 30 month earn out period

 

 

5,000 

 

7.7 

 

 

4,608 



 

$

10,000 

 

 

 

$

5,847 





The valuation of contingent consideration was initially based on a weighted-average discounted cash flow model.  The fair value is reviewed and estimated on a quarterly basis based on the probability of achieving defined milestones and current interest rates.  Significant changes in any of the unobservable inputs used in the fair value measurement of contingent consideration could result in a significantly lower or higher fair value.  An increase or decrease in the probability of achieving certain milestones within the earn out period would be accompanied by a directionally similar change in the fair value of the recorded liability.  A change in discount rate would be accompanied by a directionally opposite change in fair value.  Changes in the fair value of the recorded liability are reported in research and development expense in the consolidated condensed statements of income.  In the current fiscal year, changes in milestone estimates in Tranche A above occurred following the review of product shipment forecasts within the earn out period.  The revised estimates reduced the fair value of the liability as of December 24, 2016 as shown in the table below. 







 

 



Nine Months Ended



December 24,



2016



(in thousands)

Beginning balance

$

9,068 

Adjustment to estimates (research and development expense)

 

(3,554)

Fair value charge recognized in earnings (research and development expense)

 

333 

Ending balance

$

5,847 



Accounts Receivable, net
Accounts Receivable, net

5.     Accounts Receivable, net



The following are the components of accounts receivable, net (in thousands):



 

 

 

 

 



 

 

 

 

 



December 24,

 

March 26,



2016

 

2016

Gross accounts receivable

$

247,081 

 

$

89,007 

Allowance for doubtful accounts

 

(451)

 

 

(475)

Accounts receivable, net

$

246,630 

 

$

88,532 



The significant increase in accounts receivable is due primarily to the volume and timing of shipments in the current fiscal year.

Inventories
Inventories



6.     Inventories



Inventories are comprised of the following (in thousands):



 

 

 

 

 



 

 

 

 

 



December 24,

 

March 26,



2016

 

2016

Work in process

$

118,513 

 

$

67,827 

Finished goods

 

35,615 

 

 

74,188 



$

154,128 

 

$

142,015 



Revolving Credit Facilities
Revolving Credit Facilities

7.     Revolving Credit Facilities



On August 29, 2014, Cirrus Logic entered into a credit agreement (the “Credit Agreement”) with Wells Fargo Bank, National Association, as Administrative Agent, and the Lenders party thereto.    The Credit Agreement provided for a $250 million senior secured revolving credit facility (the “Credit Facility”).  Borrowings under the Credit Facility were used for general corporate purposes.



On July 12, 2016, Cirrus Logic entered into an amended and restated credit agreement (the “Amended Credit Agreement”) with Wells Fargo Bank, National Association, as Administrative Agent, and the Lender party thereto, for the purpose of refinancing the Credit Facility and providing ongoing working capital.  The Amended Credit Agreement provides for a $300 million senior secured revolving credit facility (the “Amended Facility”) with a $25 million letter of credit sublimit.  The Amended Facility matures on July 12, 2021.  Cirrus Logic must repay the outstanding principal amount of all borrowings, together with all accrued but unpaid interest thereon, on the maturity date.  The Amended Facility is required to be guaranteed by all of Cirrus Logic’s material domestic subsidiaries (the “Subsidiary Guarantors”).  The Credit Facility is secured by substantially all of the assets of Cirrus Logic and any Subsidiary Guarantors, except for certain excluded assets.



Borrowings under the Amended Facility may, at our election, bear interest at either (a) a base rate plus the applicable margin (“Base Rate Loans”) or (b) a LIBOR rate plus the applicable margin (“LIBOR Rate Loans”). The applicable margin ranges from 0% to 0.50% per annum for Base Rate Loans and 1.25% to 2.00% per annum for LIBOR Rate Loans based on the Leverage Ratio (as defined below).  A commitment fee accrues at a rate per annum ranging from 0.20% to 0.30% (based on the Leverage Ratio) on the average daily unused portion of the commitment of the lenders.  The Amended Credit Agreement contains certain financial covenants providing that (a) the ratio of consolidated funded indebtedness to consolidated EBITDA for the prior four fiscal quarters must not be greater than 3.00 to 1.00 (the “Leverage Ratio”) and (b) the ratio of consolidated EBITDA for the prior four consecutive fiscal quarters to consolidated fixed charges (including amounts paid in cash for consolidated interest expenses, capital expenditures, scheduled principal payments of indebtedness, and income taxes) for the prior four consecutive fiscal quarters must not be less than 1.25 to 1.00 as of the end of each fiscal quarter.  The Amended Credit Agreement also contains negative covenants limiting the Company’s or any Subsidiary’s ability to, among other things, incur debt, grant liens, make investments, effect certain fundamental changes, make certain asset dispositions, and make certain restricted payments. 

   

At December 24, 2016, the Company was in compliance with all covenants under the Amended Credit Agreement.  The Company had borrowed $100.0 million under this facility as of December 24, 2016, which is included in long-term liabilities on the consolidated condensed balance sheets under the caption “Debt.”



Patent Agreement and Other
Patent Agreement Net Text Block

8.   Patent Agreement and Other



On May 8, 2015, we entered into a patent purchase agreement for the sale of certain Company-owned patents relating to our LED lighting products.  As a result of this agreement, on June 22, 2015, the Company received cash consideration of $12.5 million from the purchaser.  Under the agreement, the Company undertook to no longer be engaged in LED lighting and received a license under the sold patents for all other fields of use.  The proceeds were recorded during the first quarter of fiscal year 2016 as a recovery of costs previously incurred and are reflected as a separate line item on the consolidated condensed statements of income in operating expenses under the caption Patent agreement and other.”  Additionally, in the second and third quarter of fiscal year 2016, the Company recorded $0.8 million and $0.1 million, respectively, in expense related to a negotiated adjustment to a legal settlement, which is reflected under the same caption.



Income Taxes
Income Taxes

10.   Income Taxes



Our provision for income taxes is based on estimated effective tax rates derived from an estimate of annual consolidated earnings before taxes, adjusted for nondeductible expenses, other permanent items and any applicable credits.



The following table presents the provision for income taxes (in thousands) and the effective tax rates:





 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 



Three Months Ended

 

Nine Months Ended



December 24,

 

December 26,

 

December 24,

 

December 26,



2016

 

2015

 

2016

 

2015

Income before income taxes

$

145,792 

 

$

62,395 

 

$

270,134 

 

$

154,876 

Provision for income taxes

$

23,751 

 

$

21,011 

 

$

43,983 

 

$

45,258 

Effective tax rate

 

16.3% 

 

 

33.7% 

 

 

16.3% 

 

 

29.2% 



Our income tax expense was $23.8 million and $44.0 million for the third quarter and first nine months of fiscal year 2017, respectively.  Our effective tax rate was 16.3% for both the third quarter and first nine months of fiscal year 2017.  Our income tax expense was $21.0 million and $45.3 million for the third quarter and first nine months of fiscal year 2016, respectively.  Our effective tax rate was 33.7% and 29.2% for the third quarter and first nine months of fiscal year 2016, respectively.  Our income tax expense includes $2.2 million, $8.0 million, and $10.8 million of tax benefit for the first, second, and third quarters of fiscal year 2017, respectively, from the early adoption of the ASU 2016-09 accounting standard.  Please refer to Note 2 for further information.



Our effective tax rate for the third quarter and first nine months of fiscal year 2017 was lower than the federal statutory rate primarily due to income earned in certain foreign jurisdictions taxed below the federal statutory rate and the recognition of tax benefits in the period in which they occur for early adoption of the ASU 2016-09 accounting standard.  Our effective tax rate for the third quarter and first nine months of fiscal year 2016 was below the federal statutory rate primarily due to the permanent extension of the U.S. R&D credit in the third quarter of fiscal 2016.  Our effective tax rate for the first nine months of fiscal 2016 was further reduced by a one-time tax benefit associated with deferred taxes related to U.S. R&D credit carryforwards recorded in the second quarter of fiscal year 2016.



The Company records unrecognized tax benefits for the estimated risk associated with tax positions taken on tax returns.  At December 24, 2016, the Company had unrecognized tax benefits of $29.0 million, all of which would impact the effective tax rate if recognized.  The Company’s total unrecognized tax benefits are classified as either Other long-term liabilities” in the consolidated condensed balance sheets or as a reduction to deferred tax assets to the extent that the unrecognized tax benefit relates to deferred tax assets.



 The Company recognizes interest and penalties related to unrecognized tax benefits in the provision for income taxesThe Company recognized $0.2 million of interest in the provision for income taxes during the first nine months of fiscal year 2017.  As of December 24, 2016, the balance of accrued interest and penalties, net of tax was $0.2 million.  No interest or penalties were recognized during the first nine months of fiscal year 2016.



The Company believes it is reasonably possible that the gross unrecognized tax benefits could decrease by approximately $2.3 million in the next 12 months due to the lapse of the statute of limitations applicable to a tax deduction claimed on a prior year tax return.



The Company and its subsidiaries are subject to U.S. federal income tax as well as income tax in multiple state and foreign jurisdictions.  Fiscal years 2014 through 2016 remain open to examination by the major taxing jurisdictions to which the Company is subject, although carry forward attributes that were generated in tax years prior to fiscal year 2014 may be adjusted upon examination by the tax authorities if they have been, or will be, used in a future period.  The Company is not currently under an income tax audit in any major taxing jurisdiction. 

Net Income Per Share
Net Income Per Share

11.   Net Income Per Share



Basic net income per share is based on the weighted effect of common shares issued and outstanding and is calculated by dividing net income by the basic weighted average shares outstanding during the period.  Diluted net income per share is calculated by dividing net income by the weighted average number of common shares used in the basic net income per share calculation, plus the equivalent number of common shares that would be issued assuming exercise or conversion of all potentially dilutive common shares outstanding.  Prior to fiscal year 2017, these potentially dilutive items consisted primarily of the tax affected outstanding stock options and awards (including restricted stock units and market stock units).  As mentioned previously, the Company adopted ASU 2016-09, Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting in the current fiscal quarter.  All adjustments related to the adoption are shown as of the beginning of the fiscal year.  Therefore, in the current fiscal year, these potentially dilutive items consist primarily of outstanding stock options and awards (including restricted stock units and market stock units), without any estimated excess tax benefits and deficiencies in the calculation of assumed proceeds under the Treasury Stock Method, as such amounts are now recognized in the income statement. 



The following table details the calculation of basic and diluted earnings per share for the three and nine months ended December 24, 2016 and December 26, 2015 (in thousands, except per share amounts):







 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 



Three Months Ended

 

Nine Months Ended



December 24,

 

December 26,

 

December 24,

 

December 26,



2016

 

2015

 

2016

 

2015

Numerator:

 

 

 

 

 

 

 

 

 

 

 

Net income

$

122,041 

 

$

41,384 

 

$

226,151 

 

$

109,618 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

63,837 

 

 

63,328 

 

 

63,025 

 

 

63,316 

Effect of dilutive securities

 

2,911 

 

 

2,433 

 

 

3,353 

 

 

2,868 

Weighted average diluted shares

 

66,748 

 

 

65,761 

 

 

66,378 

 

 

66,184 

Basic earnings per share

$

1.91 

 

$

0.65 

 

$

3.59 

 

$

1.73 

Diluted earnings per share

$

1.83 

 

$

0.63 

 

$

3.41 

 

$

1.66 



The weighted outstanding shares excluded from our diluted calculation for the three and nine months ended December 24, 2016 were 157 thousand and 208 thousand, respectively, as the shares were anti-dilutive.  The weighted outstanding shares excluded from our diluted calculation for the three and nine months ended December 26, 2015 were 563 thousand and 374 thousand, respectively, as the shares were anti-dilutive.     

Legal Matters
Legal Matters

12.   Legal Matters

From time to time, we are involved in legal proceedings concerning matters arising in connection with the conduct of our business activities.  We regularly evaluate the status of legal proceedings in which we are involved in order to assess whether a loss is probable or there is a reasonable possibility that a loss or additional loss may have been incurred, and to determine if accruals are appropriate.  We further evaluate each legal proceeding to assess whether an estimate of possible loss or range of loss can be made. 



Based on current knowledge, management does not believe that there are any pending matters that could potentially have a material adverse effect on our business, financial condition, results of operations or cash flows.  However, we are engaged in various legal actions in the normal course of business.  There can be no assurances in light of the inherent uncertainties involved in any potential legal proceedings, some of which are beyond our control, and an adverse outcome in any legal proceeding could be material to our results of operations or cash flows for any particular reporting period.



Stockholders' Equtiy
Stockholders Equity Note Disclosure Text Block

13.   Stockholders’ Equity



Common Stock 

   

The Company issued a net 0.9 million and 2.0 million shares of common stock during the three and nine month periods ending December 24, 2016, respectively, primarily pursuant to the Company’s 2006 Stock Incentive Plan.  The Company issued a net 0.6 million and 1.4 million shares of common stock during the three and nine month periods ending December 26, 2015, respectively,  in connection with stock issuances primarily pursuant to the Company’s 2006 Stock Incentive Plan.    



Share Repurchase Program   

    

Since inception, $24.2 million of the Company’s common stock has been repurchased under the Company’s 2015 $200 million share repurchase program, leaving $175.8 million available for repurchase under this plan as of December 24, 2016.  During the three and nine months ended December 24, 2016, the Company repurchased no shares and 0.5 million shares of its common stock, respectively, for $15.4 million, at an average cost of $32.13.  All of these shares were repurchased in the open market and were funded from existing cash.  All shares of our common stock that were repurchased were retired as of December 24, 2016. 



Segment Information
Segment Information

14.   Segment Information



We determine our operating segments in accordance with FASB guidelines.  Our Chief Executive Officer (“CEO”) has been identified as the chief operating decision maker under these guidelines. 



The Company operates and tracks its results in one reportable segment, but reports revenue performance in two product lines, which, currently are Portable Audio and Non-Portable Audio and Other.  Our CEO receives and uses enterprise-wide financial information to assess financial performance and allocate resources, rather than detailed information at a product line level.  Additionally, our product lines have similar characteristics and customers.  They share support functions such as sales, public relations, supply chain management, various research and development and engineering support, in addition to the general and administrative functions of human resources, legal, finance and information technology.  Therefore, no complete, discrete financial information is maintained for these product lines.

Revenues from our product lines are as follows (in thousands):



 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 



Three Months Ended

 

Nine Months Ended



December 24,

 

December 26,

 

December 24,

 

December 26,



2016

 

2015

 

2016

 

2015

Portable Audio Products

$

483,712 

 

$

308,803 

 

$

1,083,190 

 

$

801,821 

Non-Portable Audio and Other Products

 

39,317 

 

 

39,060 

 

 

127,886 

 

 

135,431 



$

523,029 

 

$

347,863 

 

$

1,211,076 

 

$

937,252 



Recently Issued Accounting Pronouncements (Tables)
Schedule of ASU 2016-09 Early Adoption Impact



 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 



 

Three Months Ended

 

 

Six Months Ended



 

June 25, 2016

 

September 24, 2016

 

 

September 24, 2016



 

As reported

 

As adjusted

 

As reported

 

As adjusted

 

 

As reported

 

As adjusted



 

(in thousands, except per share data)

Consolidated Condensed Statements of Income:

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax expense

$

5,805 

$

3,598 

$

24,608 

$

16,634 

 

$

30,413 

$

20,232 

Net income

$

15,864 

$

18,071 

$

78,065 

$

86,039 

 

$

93,929 

$

104,110 

Basic net income per share

$

0.25 

$

0.29 

$

1.24 

$

1.37 

 

$

1.50 

$

1.66 

Diluted net income per share

$

0.24 

$

0.27 

$

1.19 

$

1.30 

 

$

1.43 

$

1.58 

Weighted average shares used in diluted net income per share computation

 

65,232 

 

65,723 

 

65,717 

 

66,410 

 

 

65,521 

 

66,101 



 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated Condensed Statements of Cash Flows:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net cash provided by operating activities

$

12,226 

$

12,756 

$

19,990 

$

24,091 

 

$

32,216 

$

36,847 

Net cash used in financing activities

$

(13,140)

$

(13,670)

$

(13,859)

$

(17,960)

 

$

(26,999)

$

(31,630)



Marketable Securities (Tables)



 

 

 

 

 

 

 

 

 

Estimated



 

 

 

Gross

 

Gross

 

Fair Value



Amortized

 

Unrealized

 

Unrealized

 

(Net Carrying

As of December 24, 2016

Cost

 

Gains

 

Losses

 

Amount)

Corporate debt securities

$

36,052 

 

$

-

 

$

(36)

 

$

36,016 

Commercial paper

 

36,354 

 

 

-

 

 

(28)

 

 

36,326 

Total securities

$

72,406 

 

$

-

 

$

(64)

 

$

72,342 



The Company’s specifically identified gross unrealized losses of $64 thousand related to 18 different securities with total amortized cost of approximately $72.4 million at December 24, 2016.   Four securities had been in a continuous unrealized loss position for more than 12 months as of December 24, 2016.  The gross unrealized loss on these securities was less than one percent of the position value.  Because the Company does not intend to sell the investments at a loss and it is not more likely than not that the Company will be required to sell the investments before recovery of its amortized cost basis, it did not consider the investment in these securities to be other-than-temporarily impaired at December 24, 2016.   



The following table is a summary of available-for-sale securities at March 26, 2016 (in thousands):







 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

Estimated



 

 

 

Gross

 

Gross

 

Fair Value



 

Amortized

 

Unrealized

 

Unrealized

 

(Net Carrying

As of March 26, 2016

 

Cost

 

Gains

 

Losses

 

Amount)

Corporate debt securities

$

 

81,310 

 

$

 

$

(100)

 

$

81,213 





 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 



 

December 24, 2016

 

March 26, 2016



 

Amortized

 

Estimated

 

Amortized

 

Estimated



 

Cost

 

Fair Value

 

Cost

 

Fair Value

Within 1 year

 

$

72,406 

 

$

72,342 

 

$

60,603 

 

$

60,582 

After 1 year

 

 

 -

 

 

 -

 

 

20,707 

 

 

20,631 

Total

 

$

72,406 

 

$

72,342 

 

$

81,310 

 

$

81,213 



Fair Value of Financial Instruments (Tables)
Schedule of Fair Value of Financial Assets and Liabilities



Quoted Prices

 

 

 

 

 

 



in Active

 

Significant

 

 

 

 



Markets for

 

Other

 

Significant

 

 



Identical

 

Observable

 

Unobservable

 

 



Assets

 

Inputs

 

Inputs

 

 



Level 1

 

Level 2

 

Level 3

 

Total

Assets:

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

 

 

Money market funds

$

224,094 

 

$

 -

 

$

 -

 

$

224,094 



 

 

 

 

 

 

 

 

 

 

 

Available-for-sale securities

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

$

 -

 

$

36,016 

 

$

 -

 

$

36,016 

Commercial paper

 

 -

 

 

36,326 

 

 

 -

 

 

36,326 



$

 -

 

$

72,342 

 

$

 -

 

$

72,342 



 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

Other accrued liabilities

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration

$

 -

 

$

 -

 

$

1,239 

 

$

1,239 

Other long-term liabilities

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration

$

 -

 

$

 -

 

$

4,608 

 

$

4,608 





The following summarizes the fair value of our financial instruments at March 26, 2016, exclusive of pension plan assets and liabilities (in thousands):



 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 



Quoted Prices

 

 

 

 

 

 



in Active

 

Significant

 

 

 

 



Markets for

 

Other

 

Significant

 

 



Identical

 

Observable

 

Unobservable

 

 



Assets

 

Inputs

 

Inputs

 

 



Level 1

 

Level 2

 

Level 3

 

Total

Cash equivalents

 

 

 

 

 

 

 

 

 

 

 

Money market funds

$

79,256 

 

$

 -

 

$

 -

 

$

79,256 



 

 

 

 

 

 

 

 

 

 

 

Available-for-sale securities

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

$

 -

 

$

81,213 

 

$

 -

 

$

81,213 



 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

Other accrued liabilities

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration

$

 -

 

$

 -

 

$

4,709 

 

$

4,709 

Other long-term liabilities

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration

$

 -

 

$

 -

 

$

4,359 

 

$

4,359 



Fair Value of Financial Instruments Contingent Consideration (Tables)
Schedule of Fair Value of Financial Instruments - Contingent Consideration



 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 



 

 

Maximum Value if Milestones Achieved
(in thousands)

 

Estimated Discount Rate (%)

 

 

Fair Value
(in thousands)

Tranche A - 18 month earn out period

 

$

5,000 

 

7.0 

 

$

1,239 

Tranche B - 30 month earn out period

 

 

5,000 

 

7.7 

 

 

4,608 



 

$

10,000 

 

 

 

$

5,847 



Schedule of Fair Value of Contingent Consideration Rollforward (Table)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]



 

 



Nine Months Ended



December 24,



2016



(in thousands)

Beginning balance

$

9,068 

Adjustment to estimates (research and development expense)

 

(3,554)

Fair value charge recognized in earnings (research and development expense)

 

333 

Ending balance

$

5,847 



Accounts Receivable, net (Tables)
Components of Accounts Receivable, net



 

 

 

 

 



 

 

 

 

 



December 24,

 

March 26,



2016

 

2016

Gross accounts receivable

$

247,081 

 

$

89,007 

Allowance for doubtful accounts

 

(451)

 

 

(475)

Accounts receivable, net

$

246,630 

 

$

88,532 



Inventories (Tables)
Schedule of Inventories



 

 

 

 

 



 

 

 

 

 



December 24,

 

March 26,



2016

 

2016

Work in process

$

118,513 

 

$

67,827 

Finished goods

 

35,615 

 

 

74,188 



$

154,128 

 

$

142,015 



Income Taxes (Tables)
Schedule of Provision for Income Taxes and Effective Tax Rates



 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 



Three Months Ended

 

Nine Months Ended



December 24,

 

December 26,

 

December 24,

 

December 26,



2016

 

2015

 

2016

 

2015

Income before income taxes

$

145,792 

 

$

62,395 

 

$

270,134 

 

$

154,876 

Provision for income taxes

$

23,751 

 

$

21,011 

 

$

43,983 

 

$

45,258 

Effective tax rate

 

16.3% 

 

 

33.7% 

 

 

16.3% 

 

 

29.2% 



Net Income Per Share (Tables)
Schedule of Earnings Per Share, Basic and Diluted



 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 



Three Months Ended

 

Nine Months Ended



December 24,

 

December 26,

 

December 24,

 

December 26,



2016

 

2015

 

2016

 

2015

Numerator:

 

 

 

 

 

 

 

 

 

 

 

Net income

$

122,041 

 

$

41,384 

 

$

226,151 

 

$

109,618 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

63,837 

 

 

63,328 

 

 

63,025 

 

 

63,316 

Effect of dilutive securities

 

2,911 

 

 

2,433 

 

 

3,353 

 

 

2,868 

Weighted average diluted shares

 

66,748 

 

 

65,761 

 

 

66,378 

 

 

66,184 

Basic earnings per share

$

1.91 

 

$

0.65 

 

$

3.59 

 

$

1.73 

Diluted earnings per share

$

1.83 

 

$

0.63 

 

$

3.41 

 

$

1.66 



Segment Information (Tables)
Schedule of Segment Revenue from Product Lines



 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 



Three Months Ended

 

Nine Months Ended



December 24,

 

December 26,

 

December 24,

 

December 26,



2016

 

2015

 

2016

 

2015

Portable Audio Products

$

483,712 

 

$

308,803 

 

$

1,083,190 

 

$

801,821 

Non-Portable Audio and Other Products

 

39,317 

 

 

39,060 

 

 

127,886 

 

 

135,431 



$

523,029 

 

$

347,863 

 

$

1,211,076 

 

$

937,252 



Recently Issued Accounting Pronouncements (Schedule of ASU 2016-09 Early Adoption Impact) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended 9 Months Ended
Dec. 24, 2016
Sep. 24, 2016
Jun. 25, 2016
Dec. 26, 2015
Sep. 24, 2016
Dec. 24, 2016
Dec. 26, 2015
Share-based compensation, excess tax benefits, amount
$ 10,800 
$ 8,000 
$ 2,200 
 
 
 
 
Cumulative effect of new accounting principle in period of adoption
5,600 
 
 
 
 
5,600 
 
Provision for income taxes
23,751 
16,634 
3,598 
21,011 
20,232 
43,983 
45,258 
Net income
122,041 
86,039 
18,071 
41,384 
104,110 
226,151 
109,618 
Basic earnings per share
$ 1.91 
$ 1.37 
$ 0.29 
$ 0.65 
$ 1.66 
$ 3.59 
$ 1.73 
Diluted earnings per share
$ 1.83 
$ 1.30 
$ 0.27 
$ 0.63 
$ 1.58 
$ 3.41 
$ 1.66 
Diluted weighted average common shares outstanding
66,748 
66,410 
65,723 
65,761 
66,101 
66,378 
66,184 
Net cash provided by operating activities
 
24,091 
12,756 
 
36,847 
244,893 
116,298 
Net cash used in financing activities
 
(17,960)
(13,670)
 
(31,630)
(76,903)
(51,351)
As Reported [Member]
 
 
 
 
 
 
 
Provision for income taxes
 
24,608 
5,805 
 
30,413 
 
 
Net income
 
78,065 
15,864 
 
93,929 
 
 
Basic earnings per share
 
$ 1.24 
$ 0.25 
 
$ 1.50 
 
 
Diluted earnings per share
 
$ 1.19 
$ 0.24 
 
$ 1.43 
 
 
Diluted weighted average common shares outstanding
 
65,717 
65,232 
 
65,521 
 
 
Net cash provided by operating activities
 
19,990 
12,226 
 
32,216 
 
 
Net cash used in financing activities
 
$ (13,859)
$ (13,140)
 
$ (26,999)
 
 
Marketable Securities (Narrative) (Details) (USD $)
Dec. 24, 2016
security
Mar. 26, 2016
security
Marketable Securities [Abstract]
 
 
Gross Unrealized Losses
$ (64,000)
$ (100,000)
Amortized cost on available for sale securities held at gross unrealized loss
$ 72,400,000 
$ 64,700,000 
Number of securities in unrealized loss position
18 
21 
Number of securities in unrealized loss position greater than one year
Marketable Securities (Schedule of Available-for-sale Securities) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 24, 2016
Mar. 26, 2016
Schedule of Available-for-sale Securities [Line Items]
 
 
Estimated Fair Value
$ 72,342 
$ 81,213 
Gross Unrealized Losses
(64)
(100)
Amortized Cost
72,406 
81,310 
Corporate Debt Securities - U.S. [Member]
 
 
Schedule of Available-for-sale Securities [Line Items]
 
 
Estimated Fair Value
36,016 
 
Gross Unrealized Losses
(36)
 
Amortized Cost
36,052 
 
Commercial Paper [Member]
 
 
Schedule of Available-for-sale Securities [Line Items]
 
 
Estimated Fair Value
36,326 
 
Gross Unrealized Losses
(28)
 
Amortized Cost
$ 36,354 
 
Marketable Securities (Schedule of Cost and Estimated Fair Value of Available-for-sale Securities by Contractual Maturity) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 24, 2016
Mar. 26, 2016
Marketable Securities [Abstract]
 
 
Within 1 year, Amortized Cost
$ 72,406 
$ 60,603 
After 1 year, Amortized Cost
 
20,707 
Amortized Cost
72,406 
81,310 
Within 1 year, Estimated Fair Value
72,342 
60,582 
After 1 year, Estimated Fair Value
 
20,631 
Estimated Fair Value
$ 72,342 
$ 81,213 
Fair Value of Financial Instruments (Schedule of Fair Value of Financial Assets and Liabilities) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 24, 2016
Mar. 26, 2016
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial liabilitites
$ 5,847 
$ 9,068 
Other Long Term Liability Contingent Consideration [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial liabilitites
4,608 
4,359 
Other Long Term Liability Contingent Consideration [Member] |
Significant Unobservable Inputs Level 3 [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial liabilitites
4,608 
4,359 
Contingent Consideration [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial liabilitites
1,239 
4,709 
Contingent Consideration [Member] |
Significant Unobservable Inputs Level 3 [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial liabilitites
1,239 
4,709 
Cash Equivalents [Member] |
Money-Market Funds [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
224,094 
79,256 
Cash Equivalents [Member] |
Money-Market Funds [Member] |
Quoted Prices In Active Markets For Identical Assets Level 1 [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
224,094 
79,256 
Available-for-sale Securities [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
72,342 
 
Available-for-sale Securities [Member] |
Significant Other Observable Inputs Level 2 [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
72,342 
 
Available-for-sale Securities [Member] |
Corporate Debt Securities [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
36,016 
81,213 
Available-for-sale Securities [Member] |
Corporate Debt Securities [Member] |
Significant Other Observable Inputs Level 2 [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
36,016 
81,213 
Available-for-sale Securities [Member] |
Commercial Paper [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
36,326 
 
Available-for-sale Securities [Member] |
Commercial Paper [Member] |
Significant Other Observable Inputs Level 2 [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
$ 36,326 
 
Fair Value of Financial Instruments (Schedule of Contingent Consideration) (Details) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Dec. 24, 2016
Mar. 26, 2016
Dec. 24, 2016
Tranche A [Member]
Dec. 24, 2016
Tranche B [Member]
Dec. 24, 2016
Weighted Average [Member]
Dec. 24, 2016
Weighted Average [Member]
Tranche A [Member]
Dec. 24, 2016
Weighted Average [Member]
Tranche B [Member]
Fair Value Inputs, Discount Rate
 
 
7.00% 
7.70% 
 
 
 
Fair Value, Net Asset (Liability)
$ 5,847 
$ 9,068 
$ 1,239 
$ 4,608 
$ 10,000 
$ 5,000 
$ 5,000 
Fair Value of Financial Instruments (Schedule of Fair Value of Contingent Consideration) (Details) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Dec. 24, 2016
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]
 
Beginning balance
$ 9,068 
Adjustment to estimates (research and development expense)
(3,554)
Fair value charge recognized in earnings (research and development expense)
333 
Ending balance
$ 5,847 
Accounts Receivable, net (Components of Accounts Receivable, net) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 24, 2016
Mar. 26, 2016
Accounts Receivable, net [Abstract]
 
 
Gross accounts receivable
$ 247,081 
$ 89,007 
Allowance for doubtful accounts
(451)
(475)
Accounts receivable, net
$ 246,630 
$ 88,532 
Inventories (Schedule of Inventories) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 24, 2016
Mar. 26, 2016
Inventories [Abstract]
 
 
Work in process
$ 118,513 
$ 67,827 
Finished goods
35,615 
74,188 
Total inventories
$ 154,128 
$ 142,015 
Revolving Credit Facilities (Narrative) (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Dec. 24, 2016
Jul. 11, 2016
Mar. 26, 2016
Dec. 24, 2016
Maximum [Member]
Dec. 24, 2016
Maximum [Member]
Base Rate [Member]
Dec. 24, 2016
Maximum [Member]
London Interbank Offered Rate (LIBOR) [Member]
Dec. 24, 2016
Minimum [Member]
Dec. 24, 2016
Minimum [Member]
Base Rate [Member]
Dec. 24, 2016
Minimum [Member]
London Interbank Offered Rate (LIBOR) [Member]
Dec. 24, 2016
Wells Fargo amended credit facility [Member]
Line of credit facilty sublimit
$ 25,000 
 
 
 
 
 
 
 
 
 
Line of credit facility maximum borrowing capacity
 
250,000 
 
 
 
 
 
 
 
300,000 
Basis spread on variable interest rate
 
 
 
 
0.50% 
 
 
0.00% 
 
 
Line of credit facility, interest rate description
 
 
 
 
 
2.00% 
 
 
1.25% 
 
Line of credit facility, unused capacity, commitment fee percentage
 
 
 
0.30% 
 
 
0.20% 
 
 
 
Covenant terms, leverage ratio requirement
300.00% 
 
 
 
 
 
 
 
 
 
Covenant Terms Fixed Charge Ratio Requirement
125.00% 
 
 
 
 
 
 
 
 
 
Long-term Line of Credit, Noncurrent
$ 100,000 
 
$ 160,439 
 
 
 
 
 
 
 
Patent Agreement and Other (Narrative) (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Dec. 26, 2015
Sep. 26, 2015
Dec. 26, 2015
Consolidated Condensed Statements of Income [Abstract]
 
 
 
Patent agreement and other
$ (78)
$ 800 
$ 11,670 
Pension Plan (Details) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Dec. 24, 2016
Employee Benefit Plans [Abstract]
 
Number of pension plan participants offered ETV
49 
Number of pension plan participants accepting ETV
Pension ETV contribution, current
$ 500 
Defined Benefit Plan, Other Changes
400 
Defined Benefit Plan, Funded Status of Plan
$ 1,100 
Income Taxes (Narrative) (Details) (USD $)
3 Months Ended 6 Months Ended 9 Months Ended
Dec. 24, 2016
Sep. 24, 2016
Jun. 25, 2016
Dec. 26, 2015
Sep. 24, 2016
Dec. 24, 2016
Dec. 26, 2015
Income Taxes [Abstract]
 
 
 
 
 
 
 
Provision for income taxes
$ 23,751,000 
$ 16,634,000 
$ 3,598,000 
$ 21,011,000 
$ 20,232,000 
$ 43,983,000 
$ 45,258,000 
Effective Income Tax Rate, Continuing Operations
16.30% 
 
 
33.70% 
 
16.30% 
29.20% 
Share-based compensation, excess tax benefits, amount
10,800,000 
8,000,000 
2,200,000 
 
 
 
 
Unrecognized Tax Benefits
29,000,000 
 
 
 
 
29,000,000 
 
Accrued interest and penalties
200,000 
   
 
 
   
200,000 
 
Interest and penalties incurred during period
 
 
 
 
 
200,000 
Decrease in Unrecognized Tax Benefits is Reasonably Possible
$ 2,300,000 
 
 
 
 
$ 2,300,000 
 
Income Taxes (Table) (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended 9 Months Ended
Dec. 24, 2016
Sep. 24, 2016
Jun. 25, 2016
Dec. 26, 2015
Sep. 24, 2016
Dec. 24, 2016
Dec. 26, 2015
Income Taxes [Abstract]
 
 
 
 
 
 
 
Income before income taxes
$ 145,792 
 
 
$ 62,395 
 
$ 270,134 
$ 154,876 
Provision for income taxes
$ 23,751 
$ 16,634 
$ 3,598 
$ 21,011 
$ 20,232 
$ 43,983 
$ 45,258 
Effective tax rate
16.30% 
 
 
33.70% 
 
16.30% 
29.20% 
Net Income Per Share (Narrative) (Details)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Dec. 24, 2016
Dec. 26, 2015
Dec. 24, 2016
Dec. 26, 2015
Net Income Per Share [Abstract]
 
 
 
 
Weighted average outstanding options excluded from diluted calculation
157 
563 
208 
374 
Net Income Per Share (Calculation Of Basic And Diluted Earnings Per Share) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended 9 Months Ended
Dec. 24, 2016
Sep. 24, 2016
Jun. 25, 2016
Dec. 26, 2015
Sep. 24, 2016
Dec. 24, 2016
Dec. 26, 2015
Net Income Per Share [Abstract]
 
 
 
 
 
 
 
Net income
$ 122,041 
$ 86,039 
$ 18,071 
$ 41,384 
$ 104,110 
$ 226,151 
$ 109,618 
Basic weighted average common shares outstanding
63,837 
 
 
63,328 
 
63,025 
63,316 
Effect of dilutive securities
2,911 
 
 
2,433 
 
3,353 
2,868 
Diluted weighted average common shares outstanding
66,748 
66,410 
65,723 
65,761 
66,101 
66,378 
66,184 
Basic earnings per share
$ 1.91 
$ 1.37 
$ 0.29 
$ 0.65 
$ 1.66 
$ 3.59 
$ 1.73 
Diluted earnings per share
$ 1.83 
$ 1.30 
$ 0.27 
$ 0.63 
$ 1.58 
$ 3.41 
$ 1.66 
Stockholders' Equity (Narrative) (Details)
3 Months Ended 9 Months Ended
Dec. 24, 2016
Dec. 26, 2015
Dec. 24, 2016
Dec. 26, 2015
Stockholder's Equity [Abstract]
 
 
 
 
Stock Issued During Period, Shares, Share-based Compensation, Gross
900,000 
600,000 
2,000,000 
1,400,000 
Stockholder's Equity (Details) (USD $)
Share data in Thousands, unless otherwise specified
9 Months Ended 14 Months Ended
Dec. 24, 2016
Dec. 24, 2016
Stockholder's Equity [Abstract]
 
 
Share repurchase program, amount approved
$ 200,000,000 
$ 200,000,000 
Repurchase and retirement of common stock, shares
500 
 
Repurchase and retirement of common stock, value
15,400,000 
24,200,000 
Average cost per share repurchased
32.13 
 
Remaining amount available for share repurchases under stock repurchase program
$ 175,800,000 
$ 175,800,000 
Segment Information (Narrative) (Details)
9 Months Ended
Dec. 24, 2016
item
segment
Segment Information [Abstract]
 
Number of reportable segments
Number of product lines
Segment Information (Schedule of Segment Revenue from Product Lines) (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Dec. 24, 2016
Dec. 26, 2015
Dec. 24, 2016
Dec. 26, 2015
Segment Reporting Information [Line Items]
 
 
 
 
Net sales
$ 523,029 
$ 347,863 
$ 1,211,076 
$ 937,252 
Portable Audio Products [Member]
 
 
 
 
Segment Reporting Information [Line Items]
 
 
 
 
Net sales
483,712 
308,803 
1,083,190 
801,821 
Non-Portable Audio and Other Products [Member]
 
 
 
 
Segment Reporting Information [Line Items]
 
 
 
 
Net sales
$ 39,317 
$ 39,060 
$ 127,886 
$ 135,431